Work

Circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide post-chemotherapy (phase 3 AFFIRM study).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.5035

Authors: Martin Fleisher, Daniel Costin Danila, Karim Fizazi, Mohammad Hirmand, Brian Selby, De Phung, Johann Sebastian De Bono, Howard I. Scher

Institutions: Memorial Sloan Kettering Cancer Center, Université Paris-Sud, Institut Gustave Roussy, Medivation, Inc. (United States), Astellas Pharma (Netherlands), Royal Marsden NHS Foundation Trust, Institute of Cancer Research

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598774811

Cites:

Cited by: 18

Related to: 10